This article explains how biomarker assay development and validation ensure reliable clinical applications through careful assay design, analytical testing, clinical validation, and regulatory alignment.
Quality control in immunoassay development ensures reliable diagnostic results through calibration standards, internal controls, validation studies, and robust assay monitoring.
This article explains why organisations outsource immunoassay and ELISA development to gain specialist expertise, improve efficiency, reduce costs, and accelerate product development.